Hepatitis, Autoimmune clinical trials
The registry lists 82 studies for Hepatitis, Autoimmune across more than 10 countries. 24 are recruiting or about to start. 59 of them are mainly about Hepatitis, Autoimmune (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-03.
Get an email when these change. Save the Hepatitis, Autoimmune studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Perspectum (4) · Xiaoli Fan (4) · TaiwanJ Pharmaceuticals Co., Ltd (3) · Yale University (3) · Children's Hospital Medical Center, Cincinnati (3) · Institute of Liver and Biliary Sciences, India (3) · University Health Network, Toronto (3) · West China Hospital (3)
What is being tested here
Drugs under test in Hepatitis, Autoimmune studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Azathioprine | 1 | 1 | 1 |
| Prednisolone | 1 | 1 | 1 |
| Inebilizumab | 1 | 1 | 1 |
| Belimumab | 1 | 0 | 1 |
| Siplizumab | 1 | 0 | 1 |
| JKB-122 | 0 | 0 | 3 |
| Mycophenolic Acid | 0 | 0 | 3 |
| HR19042 | 0 | 0 | 2 |
| Preimplantation factor, synthetic | 0 | 0 | 2 |
| Cyclosporine | 0 | 1 | 2 |
Drug classes tested here Corticosteroids 1 open · Calcineurin inhibitors 4
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 6
- Nov 2026Role of USP35 in the Detection of Ferroptosis in Juvenile Autoimmune Hepatitis · Assiut University
- Jan 2027Machine Learning for Prediction of Therapy Response in Autoimmune Hepatitis · Hannover Medical School
- Feb 2027Efficacy and Safety of Therapeutic Plasma Exchange vs Standard Medical Therapy in Severe Autoimmune Hepatitis. · Institute of Liver and Biliary Sciences, India
- May 2027Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis · Assistance Publique - Hôpitaux de Paris
- Jul 2027Molecular Characterization of Autoimmune Hepatitis: A Lipidomic Approach · Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
- Sep 2027Thyroid Disorders in Pediatric Autoimmune Hepatitis · Assiut University
Who these studies take
Of the 16 Hepatitis, Autoimmune studies recruiting now, 9 (56%) set no upper age limit and 4 (25%) stop at 75 or younger. 8 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 5 (31%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 7 (44%) | 7 (44%) |
| 18 | 15 (94%) | 15 (94%) |
| 30 | 13 (81%) | 13 (81%) |
| 40 | 13 (81%) | 13 (81%) |
| 50 | 13 (81%) | 13 (81%) |
| 65 | 13 (81%) | 13 (81%) |
| 75 | 12 (75%) | 12 (75%) |
| 85 | 10 (63%) | 10 (63%) |
Across all 82 studies, recruiting or not: 48% stop at 75 or younger and 27% at 65; 29% take children; 1% are for women only and 1% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting1
- A Trial of Inebilizumab in Participants With Autoimmune HepatitisOct 16, 2026NCT07598825
Studies
Recruiting first, then most recently updated. Showing 50 of 82. Browse all 82 → or search them.
- A Trial of Inebilizumab in Participants With Autoimmune HepatitisRecruitingNCT07598825Phase 38 countries
- Belimumab in Autoimmune HepatitisRecruitingNCT06381453Phase 21 country
- Thyroid Disorders in Pediatric Autoimmune HepatitisNot yet recruitingNCT07827235
- A-LiNK: Improving Outcomes in Autoimmune Liver DiseaseRecruitingNCT057504981 country
- MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver DiseaseRecruitingNCT031786301 country
- MRI Based Biomarkers in Pediatric Autoimmune Liver DiseaseRecruitingNCT031754711 country
- Molecular Characterization of Autoimmune Hepatitis: A Lipidomic ApproachNot yet recruitingNCT076449361 country
- PredIcting sterOid depeNdEnt livEr injuRy With Polyreactive Immunoglobulin GRecruitingNCT058104801 country
- Host-Diet-Gut Interaction Post Vegan Diet in Pediatric Autoimmune Hepatitis.RecruitingNCT07118657Not applicable1 country
- Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis PatientsRecruitingNCT06250309Not applicable1 country
- Liver-gut Axis Study Through Identification of Liver Disease-specific MicrobiomeRecruitingNCT065191621 country
- A Study of SIPLIZUMAB in AILD and LT PatientsRecruitingNCT06455280Phase 11 country
- Swiss Autoimmune Hepatitis Cohort StudyRecruitingNCT031468841 country
- Role of USP35 in the Detection of Ferroptosis in Juvenile Autoimmune HepatitisNot yet recruitingNCT06896383
- Efficacy and Safety of Therapeutic Plasma Exchange vs Standard Medical Therapy in Severe Autoimmune Hepatitis.Not yet recruitingNCT06855667Not applicable1 country
- Induction of Remission in Autoimmune Hepatitis With Azathioprine vs. MMFNot yet recruitingNCT06650124Phase 2/3
- Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesRecruitingNCT056352661 country
- A Study on Factors of Biochemical Response in Autoimmune HepatitisNot yet recruitingNCT063565061 country
- Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune HepatitisNot yet recruitingNCT05473403Not applicable1 country
- Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample StorageRecruitingNCT060780981 country
- Pattern of Autoimmune Hepatitis in Children In Sohag University HospitalNot yet recruitingNCT060209761 country
- Autoimmune Hepatitis Cohort in ChinaRecruitingNCT057857931 country
- An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic SteatosisRecruitingNCT053356031 country
- Canadian Network for Autoimmune Liver DiseaseRecruitingNCT035698261 country
- Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and InflammationCompletedNCT049028071 country
- Deciphering the Self-antigen Specific T Cell Signature of Autoimmune Liver DiseasesCompletedNCT077848811 country
- TruGraf Liver Gene Expression Serial TestTerminatedNCT060613411 country
- Discrimination of DILI and AIH by Artificial IntelligenceCompletedNCT055323451 country
- ADCC Mediated B-Cell dEpletion and BAFF-R BlockadeCompletedNCT03217422Phase 2/310 countries
- Machine Learning for Prediction of Therapy Response in Autoimmune HepatitisActive, not recruitingNCT073782021 country
- Liver Cirrhosis Network Cohort StudyActive, not recruitingNCT057403581 country
- A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)CompletedNCT05569759Phase 21 country
- Repeatability and Reproducibility of Multiparametric MRICompletedNCT037432722 countries
- Relative Bioavailability Study of HR19042 in Healthy SubjectsCompletedNCT06922305Phase 11 country
- A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis.CompletedNCT05476900Phase 21 country
- Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIHActive, not recruitingNCT02997878Phase 1/21 country
- Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive MedicationActive, not recruitingNCT047986251 country
- AIH Risk Stratification With Multiparametric MRITerminatedNCT043396211 country
- Effect of RO7049665 on the Time to Relapse Following Steroid Tapering in Participants With Autoimmune Hepatitis (AIH)TerminatedNCT04790916Phase 28 countries
- Mycophenolate Mofetil Versus Azathioprine in Treatment Naive Autoimmune HepatitisStatus unknownNCT02900443Phase 42 countries
- UDCA in the Treatment of COVID-19 Infection and Its Clinical Prognosis in Patients With Autoimmune Liver DiseaseStatus unknownNCT058126121 country
- "Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Identification With Antibiotics in Children"CompletedNCT03069976Not applicable1 country
- Study of the Clinical Features of Autoimmune HepatitisStatus unknownNCT029945371 country
- Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line TherapyStatus unknownNCT05221411Phase 41 country
- Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With CirrhosisStatus unknownNCT051813321 country
- De Novo Autoimmune Hepatitis in Pediatric Liver TransplantationTerminatedNCT02056054
- Abatacept for Treatment of Recurrent or de Novo Autoimmune HepatitisTerminatedNCT04203875Phase 11 country
- Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap SyndromeStatus unknownNCT02936596Not applicable1 country
- The Role of Sodium Chloride and the Treg/Th17 Axis in Autoimmune HepatitisCompletedNCT02050646Not applicable
- Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory DiseasesCompletedNCT01988506Phase 21 country